DGAP-News: INDUS Holding AG / Key word(s): AGM/EGM INDUS Annual Shareholders' Meeting decides dividend raise 03.06.2015 / 15:34 --------------------------------------------------------------------- INDUS Annual Shareholders' Meeting decides dividend raise - Businesses performing according to plan in the first five months of the year - Raguse GmbH joins Medical Engineering segment Bergisch Gladbach, 3 June 2015 - Based on its performance during the first five months of the year, INDUS Holding AG is bullish about the company's future prospects. Speaking at today's Annual Shareholders' Meeting in Cologne, CEO Jürgen Abromeit explained the business situation and confirmed management's guidance for 2015. "We had a very promising start to the year and will continue to grow in 2015. We are planning to invest another approximately EUR 50 million in acquisitions alone," Abromeit said. In the subsequent general debate, the Board of Management emphasised that, even with competition in the M&A market appreciably stiffened, INDUS had access to a sufficient number of acquisition targets. "We are never under pressure to sign a deal - we can and will always be selective," Abromeit said. Pace of growth maintained in 2015 The strategy for 2015 revolves around continued portfolio expansion through acquisitions and further internationalisation of the group. During the year to date INDUS has acquired a production facility in Saxony and NEA International, a Dutch manufacturer of orthotic devices, for its subsidiary OFA Bamberg, thereby maintaining its declared focus on the Medical Engineering/Life Science Segment. Over the past two years a total of twelve companies were integrated into the Group. As for the current year, INDUS plans to raise sales to EUR 1.3 billion and targets an operating profit between EUR 125 and 130 million. Shareholders endorse all items on the agenda The proposals made by the Board of Management and the Supervisory Board were approved by a vast majority of the shareholders. This included a year-on-year dividend raise to EUR 1.20 per share. The total payout amounts to EUR 29.3 million, which is equivalent to a payout ratio of 46%. Moreover, the Board of Management was again authorised to purchase and use company shares by 2 June 2020. The shareholders also agreed with the proposal of the INDUS Supervisory Board, to appoint Carl Martin Welcker, Managing Partner of Alfred H. Schütte KG, Cologne, for a second term of office as a member of the Supervisory Board. Another medical technology company acquired As part of its growth strategy, INDUS has agreed to acquire a 60% stake in Raguse Gesellschaft für medizinische Produkte mbH Ascheberg, a company specialising in drapes, isolation gowns and other medical products. To differentiate itself from its competitors, Raguse also offers complete operating theatre kits configured in accordance with the lead surgeon's wishes, an interesting, high-margin niche in the market. Raguse is active in a growth market. In Germany alone, the number of operations rose by just under 25% between 2005 and 2013. An aging population and advances in medical technology suggest a further rise in the number of surgical procedures. The company was founded in 1980 and reported sales of approximately EUR 11 million for 2014. Company founder and managing director Joachim Raguse will stay on as managing shareholder, retaining a 40% stake in the company. Contact: Regina Wolter Corporate Communications & Investor Relations Phone +49 2204 4000 70 E-Mail [email protected] --------------------------------------------------------------------- 03.06.2015 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: INDUS Holding AG Kölner Straße 32 51429 Bergisch Gladbach Germany Phone: +49 (0)2204 40 00-0 Fax: +49 (0)2204 40 00-20 E-mail: [email protected] Internet: www.indus.de ISIN: DE0006200108 WKN: 620010 Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Hamburg, Munich, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 365141 03.06.2015